Tutorials
Amylyx Pharmaceuticals Inc logo

Amylyx Pharmaceuticals Inc

$ 24.92 -0.8 (-3.11%) 10:08 PM EST
P/E:
At Loss
P/B:
5.98
Market Cap:
$ 1.46B
Enterprise V:
$ 1.21B
Volume:
712.62K
Avg Vol (2M):
769.88K
Volume:
712.62K
Market Cap $:
1.46B
PE Ratio:
At Loss
Avg Vol (2-Month):
769.88K
Enterprise Value $:
1.21B
PB Ratio:
5.98
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Amylyx Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
43 Thorndike Street, Cambridge, MA, USA, 02141
Description
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 35.49
Equity-to-Asset 0.88
Debt-to-Equity 0.03
Debt-to-EBITDA -0.09
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 48
9-Day RSI 57.48
14-Day RSI 61.3
6-1 Month Momentum % -13.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.58
Quick Ratio 9.58
Cash Ratio 9.21

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-31 Est.)

AMLX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:AMLX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.443
Beta 0
Volatility % 0
14-Day RSI 61.3
14-Day ATR ($) 2.010546
20-Day SMA ($) 23.153
12-1 Month Momentum % 0
52-Week Range ($) 6.51 - 33.41
Shares Outstanding (Mil) 58.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Amylyx Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More